Literature DB >> 8925119

Bilateral vestibular loss in vertebrobasilar dolichoectasia.

D Nuti1, S Passero, S Di Girolamo.   

Abstract

Bilateral vestibular loss (BVL) is a relatively uncommon syndrome that may produce problems of balance; unsteady gait, especially in the dark; and visual disorders and/or oscillopsia associated with walking and head movements. Sometimes patients with BVL remain asymptomatic. Ototoxic drugs are the most frequently identified cause of BVL, but there are many other possible causes. The aetiology remains unknown in a large percentage of patients. In some, vascular aetiology may be suspected. Here we report 4 cases of vertebrobasilar dolichoectasia (VBD) and symptomatic BVL. In 3 subjects, hearing was preserved, but in the 4th, there was retrolabyrinthine hearing loss. In our opinion, VBD may be the cause of BVL associated or not associated with hearing loss, the reason being that since the anterior vestibular artery is small and has no anastomoses, the horizontal semicircular canal is selectively susceptible to ischemia.

Entities:  

Mesh:

Year:  1996        PMID: 8925119

Source DB:  PubMed          Journal:  J Vestib Res        ISSN: 0957-4271            Impact factor:   2.435


  3 in total

1.  Vertebrobasilar dolichoectasia diagnosed by magnetic resonance angiography and risk of stroke and death: a cohort study.

Authors:  E E Ubogu; O O Zaidat
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-01       Impact factor: 10.154

2.  Full Spectrum of Reported Symptoms of Bilateral Vestibulopathy Needs Further Investigation-A Systematic Review.

Authors:  Florence Lucieer; Stijn Duijn; Vincent Van Rompaey; Angelica Pérez Fornos; Nils Guinand; Jean Philippe Guyot; Herman Kingma; Raymond van de Berg
Journal:  Front Neurol       Date:  2018-06-04       Impact factor: 4.003

3.  The effect of microvascular decompression for hemifacial spasm caused by vertebrobasilar dolichoectasia.

Authors:  Jeong-Han Kang; Dong-Wan Kang; Sang Sup Chung; Jin Woo Chang
Journal:  J Korean Neurosurg Soc       Date:  2012-08-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.